hph014-global-alzheimers-drugs-market

Alzheimer's Drugs – A Global Market Overview

Published Date: Sep 2024

Report Code: HPH014

Pages: 253

Charts: 198

Alzheimer's Drugs Market Trends and Outlook

Alzheimer's disease is a degenerative neurological condition that progresses over time and is the primary cause of dementia, typically impacting individuals aged 65 and older. It is defined by memory loss, cognitive decline, and the formation of plaques and tangles in the brain that interrupt neuron communication. Alzheimer's disease advances in phases, ranging from mild cognitive impairment to severe dementia, though the pace varies for each person. Although there is no cure, drugs such as cholinesterase inhibitors and NMDA receptor antagonists can help delay the progression of symptoms. Combination medications, like the combination of donepezil and memantine, provide a more comprehensive treatment option for moderate to severe stages. Novel treatments like monoclonal antibodies and anti-amyloid drugs efficiently treat the disease. However, the current medicines only aim to control symptoms of Alzheimer's disease instead of reversing it.

The global market for Alzheimer's Drugs will likely maintain a robust CAGR of 9.9% during the 2024-2030 analysis period and reach a projected US$9.2 billion by 2030 from an estimated US$5.2 billion in 2024.

global-alzheimers-drugs-market

The rising prevalence of Alzheimer's disease, driven mainly by the aging population, is leading to the expansion of the Alzheimer's drugs market. With the increase in life expectancy, especially in developed countries, there is a growing number of people at risk for Alzheimer's disease, leading to a larger group of potential patients. Innovations in drug development, such as medications aimed at the root cause of illnesses, combined with increased awareness and early diagnoses, further drive this market growth. Additionally, governments and healthcare organizations are boosting their financial support for Alzheimer's research, accelerating the development of new drugs, and expediting regulatory approvals. However, several factors hinder market growth, including the high cost and complexity of drug development, frequent clinical trial failures, patent expirations, limited awareness of Alzheimer's in underdeveloped countries, and the high cost of treatments, which restrict accessibility and market potential.

Alzheimer's Drugs Regional Market Analysis

North America leads the Alzheimer's drugs market with an estimated share of 38.9% in 2024, driven by a high prevalence of the disease, recent drug approvals, and advanced healthcare systems. The region benefits from major pharmaceutical companies conducting research and clinical trials alongside an aging population. Conversely, the Asia Pacific region is projected to be the fastest-growing market, with a CAGR of 11.5% during the analysis period 2024-2030. This growth is fueled by the rising prevalence of Alzheimer's, increased awareness, and a focus on unmet medical needs, particularly in countries like China and India. The region's less stringent regulations make it an attractive location for clinical trials and drug development.

global-alzheimers-drugs-market by region

Alzheimer's Drugs Market Analysis by Drug Class

Cholinesterase inhibitors dominate the Alzheimer's drugs market, holding an estimated 42.3% share in 2024, driven by their effectiveness in treating mild-to-moderate Alzheimer's through increased acetylcholine levels. Their oral administration and proven efficacy solidify their role as primary treatment. Conversely, the others segment, which includes monoclonal antibodies, anti-amyloid beta drugs, and pipeline drugs, is expected to register the fastest CAGR of 11.9% during the analysis period 2024-2030, fueled by rising regulatory approvals and the launch of disease-modifying therapies targeting Alzheimer's pathology.

Alzheimer's Drugs Market Analysis by Route of Administration

Oral drugs lead the market with an estimated share of 57% in 2024 due to their ease of administration and non-invasive nature, which enhances patient compliance. Oral medications, such as cholinesterase inhibitors, can be self-administered, providing convenience for patients, especially elderly individuals with multiple comorbidities. The injectable segment is projected to record the fastest growth, with a CAGR of 11.7% during the forecast period from 2024 to 2030, driven by monoclonal antibodies like Aducanumab and Leqembi, which offer potential disease-modifying effects for advanced Alzheimer's stages.

global-alzheimers-drugs-market by route of administration

Alzheimer's Drugs Market Analysis by Distribution Channel

The hospital pharmacy segment dominates the market with an estimated 47.7% share in 2024, driven by increasing procurement of prescription drugs and its role in integrated care models. Hospital pharmacies coordinate multidisciplinary approaches that include pharmaceutical interventions, counseling, and community support, ensuring comprehensive care for Alzheimer's patients. Meanwhile, the online pharmacy segment is anticipated to grow significantly, with a CAGR of 12.7% during the analysis period 2024-2030. This growth is fueled by the rising number of Alzheimer's patients and the convenience of online purchasing, which is particularly beneficial for elderly people, and disabled individuals, supported by increased internet usage and digital service adoption.

Alzheimer's Drugs Market Report Scope

This global report on Alzheimer's Drugs analyzes the market based on drug class, route of administration and distribution channels. In addition to providing profiles of major companies operating in this space, the latest corporate and industrial developments have been covered to offer a clear panorama of how and where the market is progressing.

Key Metrics

Historical Period:2021-2023
Base Year:2023
Forecast Period:2024-2030
Units:Value market in US$
Companies Mentioned: 10+

Alzheimer's Drugs Market by Geographic Region

  • North America (The United States, Canada, and Mexico)
  • Europe (Germany, France, United Kingdom, Italy, Spain, and Rest of Europe)
  • Asia-Pacific (Japan, China, India, South Korea, and Rest of Asia-Pacific)
  • South America (Brazil, Argentina, and Rest of South America)
  • Rest of World

Alzheimer's Drugs Market by Drug Class

  • Cholinesterase Inhibitors
  • NMDA Receptor Antagonists
  • Combination Drugs
  • Others (Including Monoclonal Antibodies, Anti-amyloid Beta, Nutritional supplements, and Pipeline Drugs)

Alzheimer's Drugs Market by Route of Administration

  • Oral
  • Injectable
  • Transdermal Patch

Alzheimer's Drugs Market by Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Alzheimer's Drugs Market Frequently Asked Questions (FAQs)

The global Alzheimer's Drugs market is likely to grow at a CAGR of 9.9% during the 2024-2030 analysis period.

North America is the largest market for Alzheimer's Drugs.

Asia-Pacific is the fastest growing region for Alzheimer's Drugs.

The Cholinesterase Inhibitors segment is estimated to dominate the market revenue share in 2024.

The Hospital Pharmacy segment is the largest Distribution Channel market for Alzheimer's Drugs.

Demand for Alzheimer's drugs is driven by an aging population, increased awareness and diagnosis, drug innovations, government research support, and a focus on patient-centric care.

The global market size for Alzheimer's Drugs is estimated to be US$5.2 billion in 2024 and US$9.2 billion by 2030.

PART A: GLOBAL MARKET PERSPECTIVE
1. INTRODUCTION

  • Product Outline
  • Alzheimer's Drugs Defined
  • Alzheimer's Drug Classes
    • Cholinesterase Inhibitors
    • NMDA Receptor Antagonists
    • Combination Drugs
    • Others (Including Monoclonal Antibodies, Anti-amyloid Beta, Nutritional supplements, and Pipeline Drugs)
  • Alzheimer's Drug Route of Administration
    • Oral
    • Injectable
    • Transdermal Patch
  • Alzheimer's Drug Distribution Channels
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

2. Key Market Trends
3. Key Global Players
4. Key Business & Product Trends
5. Global Market Overview

  • Global Alzheimer's Drugs Market Overview by Drug Class
    • Alzheimer's Drug Class Market Overview by Global Region
      • Cholinesterase Inhibitors
      • NMDA Receptor Antagonists
      • Combination Drugs
      • Others
  • Global Alzheimer's Drugs Market Overview by Route of Administration
    • Alzheimer's Drugs Route of Administration Market Overview by Global Region
      • Oral
      • Injectable
      • Transdermal Patch
  • Global Alzheimer's Drugs Market Overview by Distribution Channel
    • Alzheimer's Drugs Distribution Channel Market Overview by Global Region
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Pharmacy

PART B: REGIONAL MARKET PERSPECTIVE
Global Alzheimer's Drugs Market Overview by Geographic Region
REGIONAL MARKET OVERVIEW
6. North America

  • North American Alzheimer's Drugs Market Overview by Geographic Region
  • North American Alzheimer's Drugs Market Overview by Drug Class
  • North American Alzheimer's Drugs Market Overview by Route of Administration
  • North American Alzheimer's Drugs Market Overview by Distribution Channel
  • Country-wise Analysis of North American Alzheimer's Drugs Market
    • The United States
      • United States Alzheimer's Drugs Market Overview by Drug Class
      • United States Alzheimer's Drugs Market Overview by Route of Administration
      • United States Alzheimer's Drugs Market Overview by Distribution Channel
    • Canada
      • Canadian Alzheimer's Drugs Market Overview by Drug Class
      • Canadian Alzheimer's Drugs Market Overview by Route of Administration
      • Canadian Alzheimer's Drugs Market Overview by Distribution Channel
    • Mexico
      • Mexican Alzheimer's Drugs Market Overview by Drug Class
      • Mexican Alzheimer's Drugs Market Overview by Route of Administration
      • Mexican Alzheimer's Drugs Market Overview by Distribution Channel

7. Europe

  • European Alzheimer's Drugs Market Overview by Geographic Region
  • European Alzheimer's Drugs Market Overview by Drug Class
  • European Alzheimer's Drugs Market Overview by Route of Administration
  • European Alzheimer's Drugs Market Overview by Distribution Channel
  • Country-wise Analysis of European Alzheimer's Drugs Market
    • Germany
      • German Alzheimer's Drugs Market Overview by Drug Class
      • German Alzheimer's Drugs Market Overview by Route of Administration
      • German Alzheimer's Drugs Market Overview by Distribution Channel
    • France
      • French Alzheimer's Drugs Market Overview by Drug Class
      • French Alzheimer's Drugs Market Overview by Route of Administration
      • French Alzheimer's Drugs Market Overview by Distribution Channel
    • The United Kingdom
      • United Kingdom Alzheimer's Drugs Market Overview by Drug Class
      • United Kingdom Alzheimer's Drugs Market Overview by Route of Administration
      • United Kingdom Alzheimer's Drugs Market Overview by Distribution Channel
    • Italy
      • Italian Alzheimer's Drugs Market Overview by Drug Class
      • Italian Alzheimer's Drugs Market Overview by Route of Administration
      • Italian Alzheimer's Drugs Market Overview by Distribution Channel
    • Spain
      • Spanish Alzheimer's Drugs Market Overview by Drug Class
      • Spanish Alzheimer's Drugs Market Overview by Route of Administration
      • Spanish Alzheimer's Drugs Market Overview by Distribution Channel
    • Rest of Europe
      • Rest of Europe Alzheimer's Drugs Market Overview by Drug Class
      • Rest of Europe Alzheimer's Drugs Market Overview by Route of Administration
      • Rest of Europe Alzheimer's Drugs Market Overview by Distribution Channel

8. Asia-Pacific

  • Asia-Pacific Alzheimer's Drugs Market Overview by Geographic Region
  • Asia-Pacific Alzheimer's Drugs Market Overview by Drug Class
  • Asia-Pacific Alzheimer's Drugs Market Overview by Route of Administration
  • Asia-Pacific Alzheimer's Drugs Market Overview by Distribution Channel
  • Country-wise Analysis of Asia-Pacific Alzheimer's Drugs Market
    • Japan
      • Japanese Alzheimer's Drugs Market Overview by Drug Class
      • Japanese Alzheimer's Drugs Market Overview by Route of Administration
      • Japanese Alzheimer's Drugs Market Overview by Distribution Channel
    • China
      • Chinese Alzheimer's Drugs Market Overview by Drug Class
      • Chinese Alzheimer's Drugs Market Overview by Route of Administration
      • Chinese Alzheimer's Drugs Market Overview by Distribution Channel
    • India
      • Indian Alzheimer's Drugs Market Overview by Drug Class
      • Indian Alzheimer's Drugs Market Overview by Route of Administration
      • Indian Alzheimer's Drugs Market Overview by Distribution Channel
    • South Korea
      • South Korean Alzheimer's Drugs Market Overview by Drug Class
      • South Korean Alzheimer's Drugs Market Overview by Route of Administration
      • South Korean Alzheimer's Drugs Market Overview by Distribution Channel
    • Rest of Asia-Pacific
      • Rest of Asia-Pacific Alzheimer's Drugs Market Overview by Drug Class
      • Rest of Asia-Pacific Alzheimer's Drugs Market Overview by Route of Administration
      • Rest of Asia-Pacific Alzheimer's Drugs Market Overview by Distribution Channel

9. South America

  • South American Alzheimer's Drugs Market Overview by Geographic Region
  • South American Alzheimer's Drugs Market Overview by Drug Class
  • South American Alzheimer's Drugs Market Overview by Route of Administration
  • South American Alzheimer's Drugs Market Overview by Distribution Channel
  • Country-wise Analysis of Asia-Pacific Alzheimer's Drugs Market
    • Brazil
      • Brazilian Alzheimer's Drugs Market Overview by Drug Class
      • Brazilian Alzheimer's Drugs Market Overview by Route of Administration
      • Brazilian Alzheimer's Drugs Market Overview by Distribution Channel
    • Argentina
      • Argentine Alzheimer's Drugs Market Overview by Drug Class
      • Argentine Alzheimer's Drugs Market Overview by Route of Administration
      • Argentine Alzheimer's Drugs Market Overview by Distribution Channel
    • Rest of South America
      • Rest of South American Alzheimer's Drugs Market Overview by Drug Class
      • Rest of South American Alzheimer's Drugs Market Overview by Route of Administration
      • Rest of South American Alzheimer's Drugs Market Overview by Distribution Channel

10. Rest of World

  • Rest of World Alzheimer's Drugs Market Overview by Drug Class
  • Rest of World Alzheimer's Drugs Market Overview by Route of Administration
  • Rest of World Alzheimer's Drugs Market Overview by Distribution Channel

PART C: GUIDE TO THE INDUSTRY
PART D: ANNEXURE
1. RESEARCH METHODOLOGY
2. FEEDBACK

AbbVie Inc.
AstraZeneca PLC
Biogen Inc.
Daiichi Sankyo Company, Limited
Eisai Co., Ltd.
Eli Lilly and Company
F. Hoffmann-La Roche AG
H. Lundbeck A/S
Johnson & Johnson Innovative Medicine
Lupin Limited
Merck & Co., Inc.
Novartis AG
Pfizer Inc.
Teva Pharmaceutical Industries Ltd.

PLEASE SELECT LICENSE TYPE

Have a question
About this report?

EMAIL US

Subscribe to Newsletter
for all latest updates

SUBSCRIBE

RELATED REPORTS

hph018-global-antisense-rnai-therapeutics-market
Antisense & RNAi Therapeutics – A Global Market Overview

Report Code: HPH018 | Pages: 253 | Price: $4500

Published
Sep 2024

hph003-global-active-pharmaceutical-ingredients-market
Active Pharmaceutical Ingredients (API) – A Global Market Overview

Report Code: HPH003 | Pages: 359 | Price: $4500

Published
Sep 2024

hc034-global-medical-engineered-materials-market
Medical Engineered Materials – A Global Market Overview

Report Code: HC034 | Pages: 320 | Price: $4500

Published
May 2024

hc022-global-medical-adhesives-sealants-market-resin-types-applications-and-end-use-sectors

Published
Mar 2024